Stocktoria
iTonic Holdings Ltd ITOC
Nasdaq · stock · Electromedical & Electrotherapeutic Apparatus · website · IPO 2024-09-05
iTonic Holdings Ltd financials (annual)
Bars are annual figures from 2023 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Revenue | $523,031 | $448,196 | $628,591 |
| Gross profit | $327,351 | $381,155 | $470,828 |
| R&D expense | $459,135 | $93,324 | $84,474 |
| Operating income | -$5.2M | -$770,266 | -$306,680 |
| Income tax | — | $21,829 | -$19,291 |
| Net income | -$5.1M | -$660,588 | -$241,217 |
| EPS (diluted) | $-0.32 | $-0.05 | $-0.02 |
| Operating cash flow | -$3.2M | -$775,000 | -$63,636 |
| Free cash flow | -$3.2M | -$775,861 | — |
| Cash & equivalents | $1.5M | $6.2M | $217,885 |
| Inventory | $52,479 | $117,422 | $52,263 |
| Total assets | $9.1M | $6.7M | $1.6M |
| Total liabilities | $969,832 | $538,551 | $1.3M |
| Shareholders' equity | $8.1M | $6.2M | $306,272 |
Growth · year-over-year · Revenue CAGR -8.8%
| Metric | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Revenue growth | +16.7% | -28.7% | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.